A patient presents with jugular venous distention, facial edema, and cyanosis, along with elevated potassium and calcium levels. The ECG shows peaked T waves and a prolonged QT interval. What is the priority nursing intervention?

A) Administer intravenous calcium gluconate

B) Initiate aggressive hydration with isotonic fluids

C) Prepare for emergency dialysis

D) Administer oxygen therapy via nasal cannula

A patient with a known malignancy presents with superior vena cava syndrome, pronounced jugular venous distention, bilateral crackles, and ECG changes indicative of hyperkalemia. Which nursing intervention should be prioritized to address the patient's immediate life-threatening condition?

C) Administer calcium gluconate to stabilize cardiac membranes

A) Administer intravenous bisphosphonates to manage hypercalcemia

B) Initiate aggressive intravenous hydration to manage tumor lysis syndrome

C) Administer calcium gluconate to stabilize cardiac membranes

D) Prepare the patient for emergency radiation therapy to reduce tumor burden

A patient with superior vena cava syndrome and tumor lysis syndrome is experiencing worsening respiratory symptoms despite supplemental oxygen. The medical team introduces diuretics to manage suspected pulmonary edema. Which nursing intervention is most critical to prioritize in this situation?

D) Position the patient in a high Fowler's position to improve respiratory effort.

A) Monitor the patient's blood pressure closely to assess for hypotension due to diuretic therapy.

B) Encourage the patient to increase fluid intake to prevent dehydration from diuretic use.

C) Administer supplemental potassium to address potential electrolyte imbalances.

D) Position the patient in a high Fowler's position to improve respiratory effort.

A patient with superior vena cava syndrome and tumor lysis syndrome is experiencing worsening respiratory status despite initial interventions. The patient is now tachypneic with a respiratory rate of 32 breaths per minute and an oxygen saturation of 88% on supplemental oxygen. A chest X-ray reveals bilateral infiltrates, suggesting pulmonary edema. Given these findings, which is the most appropriate nursing action to prioritize?

B) Administer diuretics as ordered to manage fluid overload.

A) Increase the oxygen flow rate to improve oxygen saturation.

B) Administer diuretics as ordered to manage fluid overload.

C) Encourage deep breathing exercises to reduce respiratory rate.

D) Prepare the patient for immediate transfer to the intensive care unit.

A patient with fluid overload and tumor lysis syndrome is receiving furosemide and is showing signs of respiratory improvement but still has labored breathing and crackles. The patient's phosphate levels are elevated, and serum creatinine has increased. What is the most appropriate nursing intervention to address the patient's current condition?

C) Implement a low-phosphate diet and administer phosphate binders as prescribed.

A) Increase the dosage of furosemide to enhance diuresis and reduce fluid overload.

B) Administer calcium supplements to correct the elevated phosphate levels.

C) Implement a low-phosphate diet and administer phosphate binders as prescribed.

D) Restrict fluid intake to prevent further renal compromise.

A patient with fluid overload and tumor lysis syndrome is receiving furosemide to manage her condition. After two hours, she shows slight improvement in respiratory rate and oxygen saturation, but her heart rate remains elevated, and she has frequent premature ventricular contractions. Her serum creatinine has increased, indicating potential renal compromise. Which of the following is the most appropriate nursing intervention to prioritize in this scenario?

C) Notify the healthcare provider about the changes in laboratory values and vital signs.

A) Increase the dose of furosemide to promote further diuresis.

B) Initiate supplemental oxygen therapy to improve oxygenation.

C) Notify the healthcare provider about the changes in laboratory values and vital signs.

D) Encourage the patient to increase oral fluid intake to support renal function.

A patient in the intensive care unit with a history of tumor lysis syndrome is experiencing frequent premature ventricular contractions. Her current lab results show a potassium level of 3.4 mEq/L and phosphate level of 5.4 mg/dL. What is the priority nursing intervention to address these findings?

A) Administer intravenous potassium chloride as ordered.

B) Increase the rate of high-flow oxygen therapy.

C) Prepare the patient for renal replacement therapy.

D) Administer a phosphate binder as ordered.

A patient with ongoing pulmonary congestion and signs of tumor lysis syndrome is being managed in the ICU. Her potassium level has decreased to 3.4 mEq/L due to diuretic therapy. Which of the following nursing interventions should be prioritized to prevent further complications?

A) Administer a potassium chloride supplement as prescribed and monitor cardiac rhythm.

B) Increase the rate of diuretic infusion to enhance fluid removal and reduce pulmonary congestion.

C) Initiate a high-phosphate diet to address the patient's elevated phosphate levels.

D) Withhold all electrolyte supplementation to avoid potential electrolyte overload.

A patient with worsening respiratory distress and signs of fluid overload is under evaluation. Her oxygen saturation is 88% on high-flow oxygen, and she has significant pleural effusions. Additionally, her renal function is deteriorating, with creatinine rising to 2.8 mg/dL and urine output less than 20 mL/hour. What is the nurse's priority intervention to address her condition?

B) Prepare the patient for non-invasive ventilation to support breathing and improve oxygenation.

A) Increase the flow rate of the high-flow oxygen to further improve oxygenation.

B) Prepare the patient for non-invasive ventilation to support breathing and improve oxygenation.

C) Encourage fluid intake to support renal perfusion and improve kidney function.

D) Administer a diuretic to promote fluid removal and reduce pulmonary congestion.

A patient with respiratory distress, significant pleural effusions, and worsening renal function is being evaluated by the interdisciplinary team. Which nursing action is the most appropriate to prioritize at this time?

B) Prepare the patient for non-invasive ventilation to improve oxygenation

A) Administer a diuretic to reduce fluid overload

B) Prepare the patient for non-invasive ventilation to improve oxygenation

C) Increase the oxygen flow rate to maximize saturation levels

D) Initiate renal replacement therapy to manage electrolyte imbalances

Oncologic emergencies - Nursing Case Study

Pathophysiology

• Primary mechanism: Tumor lysis syndrome occurs when cancer cells break down rapidly, releasing intracellular contents like potassium, phosphate, and nucleic acids into the bloodstream, causing metabolic imbalances.

• Secondary mechanism: Superior vena cava syndrome results from tumor obstruction of the superior vena cava, leading to impaired venous return from the head, neck, and upper extremities, causing swelling and potential respiratory distress.

• Key complication: Hypercalcemia of malignancy stems from cancer-driven osteoclastic bone resorption or parathyroid hormone-related peptide production, leading to elevated calcium levels, which can cause neurological and cardiac dysfunction.

Patient Profile

Demographics:

67-year-old female, retired school teacher

History:

• Key past medical history: Breast cancer diagnosed 3 years ago, hypertension, type 2 diabetes

• Current medications: Tamoxifen, Metformin, Lisinopril, Atorvastatin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Shortness of breath and chest pain

• Key symptoms: Fatigue, cough, fever, swelling in legs

• Vital signs: Blood pressure 160/95 mmHg, heart rate 110 bpm, respiratory rate 28 breaths per minute, temperature 101.3°F, oxygen saturation 88% on room air

Section 1

As the nursing team conducts an initial assessment, further details about the patient's condition begin to emerge. The physical examination reveals pronounced jugular venous distention, facial edema, and cyanosis, particularly noticeable around the lips and fingertips, suggesting a significant compromise in venous return. Auscultation of the lungs reveals bilateral crackles, indicative of fluid accumulation, possibly related to the superior vena cava syndrome. Palpation of the lower extremities confirms pitting edema, a sign that could correlate with both her cardiac and oncologic complications.

Lab results return, revealing critical electrolyte imbalances: elevated potassium at 6.1 mEq/L, phosphate at 5.5 mg/dL, and uric acid at 9 mg/dL, consistent with tumor lysis syndrome. Additionally, the calcium level is alarmingly high at 12.5 mg/dL, confirming hypercalcemia of malignancy. These findings underscore the interplay between the ongoing oncologic processes and her presenting symptoms. The patient's ECG shows signs of hyperkalemia, with peaked T waves and a prolonged QT interval, raising the concern for potential cardiac arrhythmias.

The patient's condition necessitates immediate intervention. The medical team initiates aggressive hydration and administers medications such as allopurinol to address the tumor lysis syndrome. Calcium-lowering strategies are employed, including intravenous bisphosphonates, to manage the hypercalcemia. Oxygen therapy is started to improve her saturation levels, while preparations for potential chemotherapy or radiation therapy are considered to address the underlying malignancy causing the superior vena cava syndrome. These interventions aim to stabilize the patient, yet the complexity of her condition requires careful monitoring and anticipatory planning for further deterioration or new complications.

Section 2

As the interventions are underway, the patient's response to treatment is closely monitored. Despite the initial efforts, her condition begins to show signs of further deterioration, prompting the medical team to reassess the situation. Approximately six hours after the initiation of therapy, the patient develops new symptoms: she becomes increasingly tachypneic with respiratory rates climbing to 32 breaths per minute, and her oxygen saturation drops to 88% despite being on supplemental oxygen. This change in respiratory status suggests a possible escalation of fluid overload or progression of pulmonary involvement, which necessitates immediate attention.

A repeat chest X-ray is ordered and reveals worsening bilateral infiltrates, indicative of pulmonary edema, likely secondary to both superior vena cava syndrome and fluid shifts from the aggressive hydration required for tumor lysis syndrome. Coupled with the physical exam findings of crackles and increased jugular venous distention, the medical team considers the potential for acute decompensated heart failure. The decision is made to introduce diuretics cautiously, balancing the need to reduce fluid overload while maintaining renal perfusion and managing electrolyte imbalances.

As the team implements these adjustments, further laboratory tests show a slight improvement in the potassium level, now at 5.4 mEq/L, but with ongoing concerns about her calcium levels, which remain elevated at 11.8 mg/dL. The patient's cardiac monitor continues to show frequent premature ventricular contractions, reflecting ongoing cardiac irritability. This complex interplay of oncologic and cardiac symptoms requires meticulous coordination and constant reassessment, as the team prepares to escalate care, considering advanced life support measures and potential transfer to a higher level of care if her condition does not stabilize.

Section 3

As the medical team endeavors to manage the patient's fluid overload and stabilize her cardiac status, they focus on her response to the cautious administration of diuretics. Approximately two hours after the introduction of furosemide, the patient's respiratory rate decreases slightly to 28 breaths per minute, and her oxygen saturation improves to 91% on high-flow oxygen. This marginal improvement provides some relief, yet the patient still exhibits labored breathing, and auscultation reveals persistent crackles throughout both lung fields. Her jugular venous distention has reduced, suggesting partial fluid mobilization, but her heart rate remains elevated at 112 beats per minute, and the premature ventricular contractions continue to be frequent.

New laboratory results return, offering additional insights into her metabolic status. Her serum calcium has decreased to 10.9 mg/dL, reflecting a positive response to ongoing management of tumor lysis syndrome, yet her phosphate level is now elevated at 5.2 mg/dL, raising the concern for worsening electrolyte imbalances. The medical team is also alerted to a serum creatinine level increase to 1.6 mg/dL from a baseline of 1.1 mg/dL, indicating potential renal compromise. These findings necessitate a careful review of the patient's fluid management strategy and consideration of alternative therapies to address both her pulmonary status and the renal function preservation.

Given the complexity of her condition, the decision is made to initiate continuous cardiac monitoring in the intensive care unit, where advanced hemodynamic support can be offered if needed. The team's focus remains on achieving a delicate balance between aggressive oncologic treatment and the prevention of further cardiopulmonary compromise. This transition to a higher level of care underscores the critical need for ongoing reassessment and dynamic intervention strategies as the patient's clinical picture evolves.

Section 4

As the patient transitions to the intensive care unit, the medical team conducts a thorough initial assessment to establish a new baseline. Her vital signs reveal a blood pressure of 136/82 mmHg, a slight improvement, yet her heart rate remains elevated at 108 beats per minute, continuing to exhibit frequent premature ventricular contractions. Her respiratory rate has steadied at 26 breaths per minute, and while her oxygen saturation is maintained at 92% on high-flow oxygen, she still shows signs of respiratory distress, with intercostal retractions visible upon inspection. Auscultation confirms persistent bilateral crackles, indicating ongoing pulmonary congestion.

The nursing team notes that the patient's fluid balance shows a marginal negative trend, suggesting some success with diuretic therapy; however, the elevated creatinine level still looms as a concern for renal perfusion. A repeat set of laboratory tests reveals her potassium level has decreased to 3.4 mEq/L, a potential side effect of continued diuresis, necessitating prompt correction to prevent arrhythmogenic complications. Her phosphate level remains elevated at 5.4 mg/dL, reinforcing the complexity of managing tumor lysis syndrome while avoiding further kidney injury.

With these findings, the interdisciplinary team prioritizes electrolyte repletion alongside gentle diuresis, considering the addition of a phosphate binder to address hyperphosphatemia. They discuss the potential need for renal replacement therapy should her renal function continue to deteriorate. The patient's complex clinical scenario demands vigilant monitoring and dynamic adjustments to her treatment plan, emphasizing the critical interplay between oncologic management and supportive care interventions. This pivotal stage in her care requires a balance between aggressive treatment and the prevention of cascading complications, with a clear focus on stabilizing her cardiopulmonary and renal status.

Section 5

As the interdisciplinary team continues to monitor the patient, a change in her status becomes apparent. Despite ongoing interventions, her respiratory distress intensifies, with an increased respiratory rate of 30 breaths per minute and oxygen saturation dropping to 88% despite being on high-flow oxygen. The nurse notes that her intercostal retractions are more pronounced, and auscultation reveals worsening bilateral crackles, suggesting that pulmonary congestion is not yet relieved. A rapid bedside ultrasound is performed, indicating significant pleural effusions, potentially exacerbating her respiratory compromise.

Concurrently, a repeat set of laboratory tests shows further deterioration in renal function, with creatinine rising to 2.8 mg/dL, and a drop in urine output to less than 20 mL/hour over the past six hours. Her potassium level, despite repletion efforts, has only marginally improved to 3.5 mEq/L, while her phosphate level remains elevated at 5.6 mg/dL. These findings raise the concern for impending acute kidney injury, prompting the team to expedite discussions on initiating renal replacement therapy to manage both fluid overload and electrolyte imbalances effectively.

This evolving scenario underscores the urgency of reassessing the treatment strategy to prevent further decompensation. The team considers the utilization of non-invasive ventilation to improve oxygenation and explores options for more aggressive fluid removal, such as ultrafiltration, to address the persistent respiratory and renal challenges. The complexity of the patient's condition necessitates a careful reevaluation of priorities, balancing the need for immediate symptom relief with the long-term goals of stabilizing her oncologic and systemic status.